Ginsenoside Ro

Cat. No.: 0225LY-1139

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Ginsenoside Ro is a Ca²⁺ antagonist with antiplatelet effects (IC50: 155 μM) that reduces the production of TXA2 and suppresses the activity of TXAS and COX-1.

Synonym: Chikusetsusaponin 5; Polysciasaponin P3; Chikusetsusaponin V; 34367-04-9; Ginsenoside-Ro; Chikusetsusaponin 5; Chikusetsusaponin-V; (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid; beta-D-Glucopyranosiduronic acid, (3beta)-28-(beta-D-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 2-O-beta-D-glucopyranosyl-; Ginsenoside R0; Saponin V

CAS No.: 34367-04-9

Compound CID: 11815492

Formula: C₄₈H₇₆O₁₉

Formula Weight: 957.11

Specification

Targets&IC50: Ca2+ antagonistic: 155 μM

Relative Density: 1.44 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Ginsenoside Ro can be used in pharmacological studies to evaluate the anti-inflammatory and anti-thrombotic effects of oleanane-type saponins.